There was no similar effect among AUS-other nodules (SEN: 46.2% vs. 46.2% vs. 7.7%, respectively), but it is difficult to draw unambiguous conclusions in this matter due to the very rare occurrence of BRAF mutations among cancers in this subcategory in our material. Here, BRAF is linked to cancer.